989 related articles for article (PubMed ID: 8980862)
21. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
[TBL] [Abstract][Full Text] [Related]
23. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
24. [Exogenous re-infection in tuberculosis].
Tsuchiya T
Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
[TBL] [Abstract][Full Text] [Related]
25. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
26. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Multidrug-resistant Tuberculosis.
Rumende CM
Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
[TBL] [Abstract][Full Text] [Related]
29. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
30. Treatment and prevention of multidrug-resistant tuberculosis.
Bastian I; Colebunders R
Drugs; 1999 Oct; 58(4):633-61. PubMed ID: 10551435
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
[TBL] [Abstract][Full Text] [Related]
32. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of acquired MDR-TB and HIV co-infection.
Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis in Kentucky: current recommendations for empiric therapy.
Wojda B; Ahkee S; Uyamadu N; Jouja K; Ramirez JA
J Ky Med Assoc; 1997 Mar; 95(3):98-101. PubMed ID: 9071852
[TBL] [Abstract][Full Text] [Related]
35. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
[TBL] [Abstract][Full Text] [Related]
36. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
[TBL] [Abstract][Full Text] [Related]
37. Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014.
Chuang PH; Wu MH; Fan SY; Lin KY; Jou R
PLoS One; 2016; 11(11):e0165222. PubMed ID: 27846235
[TBL] [Abstract][Full Text] [Related]
38. [Multi-drug-resistant tuberculosis in a Department of Infectious Diseases].
Constant CA; Ferreira PB; Valadas E; Antunes F
Acta Med Port; 2004; 17(2):157-66. PubMed ID: 15921647
[TBL] [Abstract][Full Text] [Related]
39. Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong.
Yew WW; Chan CK; Leung CC; Chau CH; Tam CM; Wong PC; Lee J
Chest; 2003 Oct; 124(4):1476-81. PubMed ID: 14555582
[TBL] [Abstract][Full Text] [Related]
40. Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Ziganshina LE; Titarenko AF; Davies GR
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004795. PubMed ID: 23744519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
